Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer

Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer

Abstract There is sparse data on the outcomes of combined chemotherapy and hormonal therapy (CHT) in patients with metastatic breast cancer (MBC). This retrospective analysis of HR-positive, HER2-negative MBC patients treated between January 2015 and December 2020 with a combination of chemotherapy...

Full description

Saved in:
Bibliographic Details
Main Authors: Kripa Bajaj, Sushmita Rath, Deep Vora, Pallavi Parab, Seema Gulia, Swapnil Rane, Tanuja Shet, Jaya Ghosh, Palak Popat, Prabhat Bhargava, Anbarasan Sekar, Anuradha Mehta, Yogesh Kembhavi, Dinesh Jethwa, Rajiv Sarin, Tabassum Wadasadawala, Shalaka Joshi, Rajendra Badwe, Sudeep Gupta
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Chemo-hormonal therapy
Hormone receptor-positive breast cancer
Online Access:https://doi.org/10.1038/s41598-025-12419-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-12419-3

Similar Items